本文已被：浏览 151次 下载 83次
投稿时间：2024-08-01 网络发布日期：2024-10-20
投稿时间：2024-08-01 网络发布日期：2024-10-20
中文摘要: 乳腺癌为女性最常见的恶性肿瘤之一，发病率位居所有恶性肿瘤前列。目前超声检查以及病理检查为乳腺癌诊断的主要方式。而乳腺癌发生及进展属于一个多免疫组化指标参与的复杂过程。乳腺癌不同免疫组化指标的表达产生不同的病理改变，进而引起一系列超声影像学改变。目前越来越多研究发现乳腺癌超声征象与乳腺癌免疫组化指标存在关联。本文通过文献调研对乳腺癌超声征象与常规免疫组化指标表达关系的研究进行归纳总结，以期为乳腺癌治疗方案的制定及预后预测提供参考。
Abstract:Breast cancer is one of the most common malignancies in women, and its incidence rate keeps ahead of all malignancies. At present, ultrasound and pathological examination are main methods for diagnosing breast cancer. The development and progression of breast cancer are a complex process involving multiple immunohistochemical indicators. Different immunohistochemical expression of breast cancer causes different pathological changes, resulting in a series of ultrasound imaging changes. More and more studies have found that ultrasound signs of breast cancer are associated with immunohistochemical indicators. Herein, the research progress on ultrasound signs of breast cancer and their relationship with the expression of immunohistochemical indicators is summarized through literature review to provide a reference for developing treatment plans and predicting the prognosis of breast cancer.
keywords: Breast cancer Ultrasonics Contrast enhanced ultrasound Ultrasonic elastography Three-dimensional ultrasound Immunohistochemistry Pathological change
文章编号： 中图分类号：R737.9 文献标志码：A
基金项目:蚌埠医科大学科研课题计划（2023byzd251）；合肥市第二人民医院科研项目（2022yyb017）
附件
引用文本：
安林林,马芳,沈莉莉,等.乳腺癌超声征象与免疫组化指标表达关系的研究进展[J].中国临床研究,2024,37(10):1489-1493.
安林林,马芳,沈莉莉,等.乳腺癌超声征象与免疫组化指标表达关系的研究进展[J].中国临床研究,2024,37(10):1489-1493.